PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WCPNX vs. NEFRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


WCPNXNEFRX
YTD Return3.94%1.84%
1Y Return9.35%9.38%
3Y Return (Ann)0.05%-2.30%
5Y Return (Ann)2.14%0.57%
10Y Return (Ann)2.69%1.66%
Sharpe Ratio1.571.31
Sortino Ratio2.371.93
Omega Ratio1.291.23
Calmar Ratio0.970.54
Martin Ratio6.604.94
Ulcer Index1.29%1.70%
Daily Std Dev5.44%6.38%
Max Drawdown-13.87%-18.76%
Current Drawdown-2.56%-7.68%

Correlation

-0.50.00.51.00.9

The correlation between WCPNX and NEFRX is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

WCPNX vs. NEFRX - Performance Comparison

In the year-to-date period, WCPNX achieves a 3.94% return, which is significantly higher than NEFRX's 1.84% return. Over the past 10 years, WCPNX has outperformed NEFRX with an annualized return of 2.69%, while NEFRX has yielded a comparatively lower 1.66% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%2.00%4.00%6.00%JuneJulyAugustSeptemberOctoberNovember
4.14%
3.73%
WCPNX
NEFRX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


WCPNX vs. NEFRX - Expense Ratio Comparison

WCPNX has a 0.89% expense ratio, which is higher than NEFRX's 0.71% expense ratio.


WCPNX
Weitz Core Plus Income Fund
Expense ratio chart for WCPNX: current value at 0.89% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.89%
Expense ratio chart for NEFRX: current value at 0.71% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.71%

Risk-Adjusted Performance

WCPNX vs. NEFRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Weitz Core Plus Income Fund (WCPNX) and Loomis Sayles Core Plus Bond Fund (NEFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WCPNX
Sharpe ratio
The chart of Sharpe ratio for WCPNX, currently valued at 1.57, compared to the broader market0.002.004.001.57
Sortino ratio
The chart of Sortino ratio for WCPNX, currently valued at 2.37, compared to the broader market0.005.0010.002.37
Omega ratio
The chart of Omega ratio for WCPNX, currently valued at 1.29, compared to the broader market1.002.003.004.001.29
Calmar ratio
The chart of Calmar ratio for WCPNX, currently valued at 0.97, compared to the broader market0.005.0010.0015.0020.0025.000.97
Martin ratio
The chart of Martin ratio for WCPNX, currently valued at 6.60, compared to the broader market0.0020.0040.0060.0080.00100.006.60
NEFRX
Sharpe ratio
The chart of Sharpe ratio for NEFRX, currently valued at 1.31, compared to the broader market0.002.004.001.31
Sortino ratio
The chart of Sortino ratio for NEFRX, currently valued at 1.93, compared to the broader market0.005.0010.001.93
Omega ratio
The chart of Omega ratio for NEFRX, currently valued at 1.23, compared to the broader market1.002.003.004.001.23
Calmar ratio
The chart of Calmar ratio for NEFRX, currently valued at 0.54, compared to the broader market0.005.0010.0015.0020.0025.000.54
Martin ratio
The chart of Martin ratio for NEFRX, currently valued at 4.94, compared to the broader market0.0020.0040.0060.0080.00100.004.94

WCPNX vs. NEFRX - Sharpe Ratio Comparison

The current WCPNX Sharpe Ratio is 1.57, which is comparable to the NEFRX Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of WCPNX and NEFRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.57
1.31
WCPNX
NEFRX

Dividends

WCPNX vs. NEFRX - Dividend Comparison

WCPNX's dividend yield for the trailing twelve months is around 5.22%, more than NEFRX's 3.94% yield.


TTM20232022202120202019201820172016201520142013
WCPNX
Weitz Core Plus Income Fund
5.22%5.73%2.93%2.23%3.31%2.72%2.55%2.11%2.43%1.78%0.58%0.00%
NEFRX
Loomis Sayles Core Plus Bond Fund
3.94%3.59%3.09%2.14%2.04%2.52%2.88%2.68%3.18%2.59%3.26%4.06%

Drawdowns

WCPNX vs. NEFRX - Drawdown Comparison

The maximum WCPNX drawdown since its inception was -13.87%, smaller than the maximum NEFRX drawdown of -18.76%. Use the drawdown chart below to compare losses from any high point for WCPNX and NEFRX. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-2.56%
-7.68%
WCPNX
NEFRX

Volatility

WCPNX vs. NEFRX - Volatility Comparison

The current volatility for Weitz Core Plus Income Fund (WCPNX) is 1.45%, while Loomis Sayles Core Plus Bond Fund (NEFRX) has a volatility of 1.74%. This indicates that WCPNX experiences smaller price fluctuations and is considered to be less risky than NEFRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


1.00%1.20%1.40%1.60%1.80%2.00%JuneJulyAugustSeptemberOctoberNovember
1.45%
1.74%
WCPNX
NEFRX